<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31853221</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>01</Day></DateCompleted><DateRevised><Year>2020</Year><Month>06</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1449-2288</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>13</Issue><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>International journal of biological sciences</Title><ISOAbbreviation>Int J Biol Sci</ISOAbbreviation></Journal><ArticleTitle>Altered Features of Vimentin-containing Cells in Cerebrum of Tg(SOD1*G93A)1Gur Mice: A Preliminary Study on Cerebrum Endogenous Neural Precursor Cells in Amyotrophic Lateral Sclerosis.</ArticleTitle><Pagination><StartPage>2830</StartPage><EndPage>2843</EndPage><MedlinePgn>2830-2843</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.7150/ijbs.33461</ELocationID><Abstract><AbstractText>Vimentin-containing cells (VCCs) are potential neural precursor cells in central nervous systems, Thus, we studied the alteration of VCCs proliferation, differentiation and migration in the cerebrum during different stages of Tg(SOD1*G93A)1Gur mice. It aims to search potential ways regulating the proliferation, differentiation and migration of endogenous VCCs, to enhance their neural repair function and to cure or prevent from the development of ALS. We observed and analyzed the proliferation, differentiation and migration of VCCs in different anatomic regions and cell types of cerebrum at different stages including the pre-onset (60-70 days), onset (90-100 days) and progression (120-130 days) of wild-type (WT) and Tg(SOD1*G93A)1Gur mice using the fluorescent immunohistochemical technology. Results showed that VCCs in the cerebrum were mostly distributed in the ventricular system, periventricular structures, the hippocampus and the cerebral cortex in WT mice. VCCs significantly reduced in the motor cortex and the cingulate cortex in Tg(SOD1*G93A)1Gur mice. All vimentin expressed in the extranuclear and almost all VCCs were astrocytes in WT mice and Tg(SOD1*G93A)1Gur mice. There were no significant difference in the number of Brdu and nestin positive cells in left and right brains of WT mice and Tg(SOD1*G93A)1Gur mice in the period of 60-130 days. Our data suggested that there existed extensively NPCs in the cerebrum of adult mice. In ALS-like Tg(SOD1*G93A)1Gur mice, VCCs in the motor cortex, the olfactory cortex and the cingulate cortex showed that no any proliferation and redistribution in neural cells of VCCs in the cerebrum occurred in all stages of ALS, might migrate to damaged regions.</AbstractText><CopyrightInformation>&#xa9; The author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Chunyan</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jiangxi Provincial People's Hospital, Affiliated People's Hospital of Nanchang University, Nanchang 330006, Jiangxi, china.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jiangxi Provincial People's Hospital, Affiliated People's Hospital of Nanchang University, Nanchang 330006, Jiangxi, china.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Qi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jiangxi Provincial People's Hospital, Affiliated People's Hospital of Nanchang University, Nanchang 330006, Jiangxi, china.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Menghua</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jiangxi Provincial People's Hospital, Affiliated People's Hospital of Nanchang University, Nanchang 330006, Jiangxi, china.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jiangxi Provincial People's Hospital, Affiliated People's Hospital of Nanchang University, Nanchang 330006, Jiangxi, china.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Zhenzhen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jiangxi Provincial People's Hospital, Affiliated People's Hospital of Nanchang University, Nanchang 330006, Jiangxi, china.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jiangxi Provincial People's Hospital, Affiliated People's Hospital of Nanchang University, Nanchang 330006, Jiangxi, china.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Renshi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jiangxi Provincial People's Hospital, Affiliated People's Hospital of Nanchang University, Nanchang 330006, Jiangxi, china.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, First Affiliated Hospital of Nanchang University, Nanchang 330006, Jiangxi, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>11</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>Int J Biol Sci</MedlineTA><NlmUniqueID>101235568</NlmUniqueID><ISSNLinking>1449-2288</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014746">Vimentin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="N">Astrocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054022" MajorTopicYN="N">Cerebrum</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="Y">cytology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058953" MajorTopicYN="N">Neural Stem Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014746" MajorTopicYN="N">Vimentin</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Astrocyte</Keyword><Keyword MajorTopicYN="N">Cerebrum</Keyword><Keyword MajorTopicYN="N">Neural precursor cells</Keyword><Keyword MajorTopicYN="N">Vimentin</Keyword></KeywordList><CoiStatement>Competing Interests: The authors have declared that no competing interest exists.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>1</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31853221</ArticleId><ArticleId IdType="pmc">PMC6909959</ArticleId><ArticleId IdType="doi">10.7150/ijbs.33461</ArticleId><ArticleId IdType="pii">ijbsv15p2830</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mitchell JD, Borasio GD. Amyotrophic lateral sclerosis. Lancet. 2007;369:2031&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">17574095</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph AC, Brettschneider J, Weishaupt JH. Amyotrophic lateral sclerosis. Current opinion in neurology. 2012;25:530&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">22918486</ArticleId></ArticleIdList></Reference><Reference><Citation>Talbott EO, Malek AM, Lacomis D. The epidemiology of amyotrophic lateral sclerosis. Handbook of clinical neurology. 2016;138:225&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">27637961</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan S, Orrell RW. Pathogenesis of amyotrophic lateral sclerosis. British medical bulletin. 2016;119:87&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">27450455</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrov D, Mansfield C, Moussy A, Hermine O. ALS Clinical Trials Review: 20 Years of Failure. Are We Any Closer to Registering a New Treatment? Frontiers in aging neuroscience. 2017;9:68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5360725</ArticleId><ArticleId IdType="pubmed">28382000</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozzoni V, Pansarasa O, Diamanti L, Nosari G, Cereda C, Ceroni M. Amyotrophic lateral sclerosis and environmental factors. Functional neurology. 2016;31:7&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4819821</ArticleId><ArticleId IdType="pubmed">27027889</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin S, Al Khleifat A, Al-Chalabi A. What causes amyotrophic lateral sclerosis? F1000Research. 2017;6:371.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5373425</ArticleId><ArticleId IdType="pubmed">28408982</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang H, Cha ES, Choi GJ, Lee WJ. Amyotrophic lateral sclerosis and agricultural environments: a systematic review. Journal of Korean medical science. 2014;29:1610&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4248580</ArticleId><ArticleId IdType="pubmed">25469059</ArticleId></ArticleIdList></Reference><Reference><Citation>Numan MS, Brown JP, Michou L. Impact of air pollutants on oxidative stress in common autophagy-mediated aging diseases. International journal of environmental research and public health. 2015;12:2289&#x2013;305.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4344726</ArticleId><ArticleId IdType="pubmed">25690002</ArticleId></ArticleIdList></Reference><Reference><Citation>Abhinav K, Al-Chalabi A, Hortobagyi T, Leigh PN. Electrical injury and amyotrophic lateral sclerosis: a systematic review of the literature. Journal of neurology, neurosurgery, and psychiatry. 2007;78:450&#x2013;453.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2117843</ArticleId><ArticleId IdType="pubmed">17098839</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinceti M. The environment and amyotrophic lateral sclerosis: converging clues from epidemiologic studies worldwide. North American journal of medical sciences. 2012;4:356&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3421914</ArticleId><ArticleId IdType="pubmed">22912944</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinceti M, Bottecchi I, Fan A, Finkelstein Y, Mandrioli J. Are environmental exposures to selenium, heavy metals, and pesticides risk factors for amyotrophic lateral sclerosis? Reviews on environmental health. 2012;27:19&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">22755265</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinceti M, Fiore M, Signorelli C, Odone A, Tesauro M, Consonni M. et al. Environmental risk factors for amyotrophic lateral sclerosis: methodological issues in epidemiologic studies. Annali d'igiene. 2012;24:407&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">23193897</ArticleId></ArticleIdList></Reference><Reference><Citation>Oskarsson B, Horton DK, Mitsumoto H. Potential Environmental Factors in Amyotrophic Lateral Sclerosis. Neurologic clinics. 2015;33:877&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4646848</ArticleId><ArticleId IdType="pubmed">26515627</ArticleId></ArticleIdList></Reference><Reference><Citation>Alfahad T, Nath A. Retroviruses and amyotrophic lateral sclerosis. Antiviral research. 2013;99:180&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3723705</ArticleId><ArticleId IdType="pubmed">23707220</ArticleId></ArticleIdList></Reference><Reference><Citation>Patten DA, Germain M, Kelly MA, Slack RS. Reactive oxygen species: stuck in the middle of neurodegeneration. Journal of Alzheimer's disease. 2010;20:S357&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">20421690</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Amico E, Factor-Litvak P, Santella RM, Mitsumoto H. Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis. Free radical biology &amp; medicine. 2013;65:509&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3859834</ArticleId><ArticleId IdType="pubmed">23797033</ArticleId></ArticleIdList></Reference><Reference><Citation>Prell T, Lautenschl&#xe4;ger J, Grosskreutz J. Calcium-dependent protein folding in amyotrophic lateral sclerosis. Cell Calcium. 2013;54:132&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">23764168</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaiswal MK. Selective vulnerability of motoneuron and perturbed mitochondrial calcium homeostasis in amyotrophic lateral sclerosis: implications for motoneurons specific calcium dysregulation. Molecular and cellular therapies. 2014;2:26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4452055</ArticleId><ArticleId IdType="pubmed">26056593</ArticleId></ArticleIdList></Reference><Reference><Citation>Leal SS, Gomes CM. Calcium dysregulation links ALS defective proteins and motor neuron selective vulnerability. Frontiers in cellular neuroscience. 2015;9:225.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4468822</ArticleId><ArticleId IdType="pubmed">26136661</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw PJ, Ince PG. Glutamate, excitotoxicity and amyotrophic lateral sclerosis. Journal of neurology. 1997;244:3&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">9178165</ArticleId></ArticleIdList></Reference><Reference><Citation>Foran E, Trotti D. Glutamate transporters and the excitotoxic path to motor neuron degeneration in amyotrophic lateral sclerosis. Antioxidants &amp; redox signaling. 2009;11:1587&#x2013;602.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2842587</ArticleId><ArticleId IdType="pubmed">19413484</ArticleId></ArticleIdList></Reference><Reference><Citation>King AE, Woodhouse A, Kirkcaldie MT, Vickers JC. Excitotoxicity in ALS: Overstimulation, or overreaction? Experimental neurology. 2016;275:162&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">26584004</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipton SA, Gu Z, Nakamura T. Inflammatory mediators leading to protein misfolding and uncompetitive/fast off-rate drug therapy for neurodegenerative disorders. International review of neurobiology. 2007;82:1&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">17678953</ArticleId></ArticleIdList></Reference><Reference><Citation>McCombe PA, Henderson RD. The Role of immune and inflammatory mechanisms in ALS. Current molecular medicine. 2011;11:246&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3182412</ArticleId><ArticleId IdType="pubmed">21375489</ArticleId></ArticleIdList></Reference><Reference><Citation>Kermer P, Liman J, Weishaupt JH, B&#xe4;hr M. Neuronal apoptosis in neurodegenerative diseases: from basic research to clinical application. Neurodegenerative disease. 2004;1:9&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">16908969</ArticleId></ArticleIdList></Reference><Reference><Citation>Okouchi M, Ekshyyan O, Maracine M, Aw TY. Neuronal apoptosis in neurodegeneration. Antioxidants &amp; redox signaling. 2007;9:1059&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">17571960</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghavami S, Shojaei S, Yeganeh B, Ande SR, Jangamreddy JR, Mehrpour M. et al. Autophagy and apoptosis dysfunction in neurodegenerative disorders. Progress in neurobiology. 2014;112:24&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">24211851</ArticleId></ArticleIdList></Reference><Reference><Citation>Radi E, Formichi P, Battisti C, Federico A. Apoptosis and oxidative stress in neurodegenerative diseases. Journal of Alzheimer's disease. 2014;42:S125&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">25056458</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez MJ, Mahy N. Neuron-Microglia Interactions in Motor Neuron Degeneration. The Inflammatory Hypothesis in Amyotrophic Lateral Sclerosis Revisited. Current medicinal chemistry. 2016;23:4753&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">27881068</ArticleId></ArticleIdList></Reference><Reference><Citation>Browne EC, Abbott BM. Recent progress towards an effective treatment of amyotrophic lateral sclerosis using the SOD1 mouse model in a preclinical setting. European journal of medicinal chemistry. 2016;121:918&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">27012524</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzini L, Vercelli A, Ferrero I, Mareschi K, Boido M, Servo S. et al. Stem cells in amyotrophic lateral sclerosis: state of the art. Expert opinion on biological therapy. 2009;9:1245&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">19663719</ArticleId></ArticleIdList></Reference><Reference><Citation>Lepore AC. Intraspinal cell transplantation for targeting cervical ventral horn in amyotrophic lateral sclerosis and traumatic spinal cord injury. Journal of visualized experiments. 2011;55(pii):3069.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3230212</ArticleId><ArticleId IdType="pubmed">21946609</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaiswal MK. Therapeutic opportunities and challenges of induced pluripotent stem cells-derived motor neurons for treatment of amyotrophic lateral sclerosis and motor neuron disease. Neural regeneration research. 2017;12:723&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5461603</ArticleId><ArticleId IdType="pubmed">28616022</ArticleId></ArticleIdList></Reference><Reference><Citation>Deda H, Inci MC, K&#xfc;rek&#xe7;i AE, Sav A, Kayihan K, Ozg&#xfc;n E. et al. Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up. Cytotherapy. 2009;11:18&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">19012065</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohl D, Pochet R, Mitrecic D, Nicaise C. Modelling and treating amyotrophic lateral sclerosis through induced-pluripotent stem cells technology. Current stem cell research &amp; therapy. 2016;11:301&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">26018231</ArticleId></ArticleIdList></Reference><Reference><Citation>Gincberg G, Arien-Zakay H, Lazarovici P, Lelkes PI. Neural stem cells: therapeutic potential for neurodegenerative diseases. British medical bulletin. 2012;104:7&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">22988303</ArticleId></ArticleIdList></Reference><Reference><Citation>Titomanlio L, Kavelaars A, Dalous J, Mani S, El Ghouzzi V, Heijnen C. et al. Stem cell therapy for neonatal brain injury: perspectives and challenges. Annals of neurology. 2011;70:698&#x2013;712.</Citation><ArticleIdList><ArticleId IdType="pubmed">22162055</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan X, Chi L, Bishop M, Luo C, Lien L, Zhang Z, Liu R. Enhanced de novo neurogenesis and dopaminergic neurogenesis in the substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- induced Parkinson's disease-like mice. Stem Cells. 2006;24:1280&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1840319</ArticleId><ArticleId IdType="pubmed">16424396</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi L, Ke Y, Luo C, Li B, Gozal D, Kalyanaraman B. et al. Motor neuron degeneration promotes neural progenitor cell proliferation, migration, and neurogenesis in the spinal cords of amyotrophic lateral sclerosis mice. Stem Cells. 2006;24:34&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1828038</ArticleId><ArticleId IdType="pubmed">16099995</ArticleId></ArticleIdList></Reference><Reference><Citation>Ke Y, Chi L, Xu R, Luo C, Gozal D, Liu R. Early response of endogenous adult neural progenitor cells to acute spinal cord injury in mice. Stem Cells. 2006;24:1011&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1857304</ArticleId><ArticleId IdType="pubmed">16339643</ArticleId></ArticleIdList></Reference><Reference><Citation>Gan L, Qiao S, Lan X, Chi L, Luo C, Lien L. et al. Neurogenic responses to amyloid-beta plaques in the brain of Alzheimer's disease-like transgenic (pPDGF-APPSw,Ind) mice. Neurobiology of disease. 2008;29:71&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2180424</ArticleId><ArticleId IdType="pubmed">17916429</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu R, Wu C, Tao Y, Yi J, Yang Y, Yang R. et al. Description of distributed features of the nestin-containing cells in brains of adult mice: a potential source of neural precursor cells. Journal of neuroscience research. 2010;88:945&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">19908282</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu R, Wu C, Tao Y, Yi J, Yang Y, Zhang X, Liu R. Nestin-positive cells in the spinal cord: a potential source of neural stem cells. International journal of developmental neuroscience. 2008;26:813&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">18611436</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazurov&#xe1; Y, Rudolf E, L&#xe1;tr I, Osterreicher J. Proliferation and differentiation of adult endogenous neural stem cells in response to neurodegenerative process within the striatum. Neurodegenerative disease. 2006;3:12&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">16909031</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilyarov AV. Nestin in central nervous system cells. Neuroscience and behavioral physiology. 2008;38:165&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">18197384</ArticleId></ArticleIdList></Reference><Reference><Citation>von Bohlen, Halbach O. Immunohistological markers for proliferative events, gliogenesis, and neurogenesis within the adult hippocampus. Cell and tissue research. 2011;345:1&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">21647561</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xe9;pinoux-Chambaud C, Eyer J. Review on intermediate filaments of the nervous system and their pathological alterations. Histochemistry and cell biology. 2013;140:13&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">23749407</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A. et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD. et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science. 1994;264:1772&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Henriques A, Pitzer C, Schneider A. Characterization of a novel SOD-1(G93A) transgenic mouse line with very decelerated disease development. PLoS one. 2010;5:e15445.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2978730</ArticleId><ArticleId IdType="pubmed">21102999</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Lu Y, Fang X, Zhang J, Li J, Li S. et al. An astrocyte regenerative response from vimentin-containing cells in the spinal cord of amyotrophic lateral sclerosis's disease-like transgenic (G93A SOD1) mice. Neurodegenerative disease. 2015;15:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">25591625</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsumoto T, Mitsushima A, Kurimura T. The role of the vimentin intermediate filaments in rat 3Y1 cells elucidated by immunoelectron microscopy and computer-graphic reconstruction. Biology of the cell. 1990;68:139&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">2192768</ArticleId></ArticleIdList></Reference><Reference><Citation>Michalczyk K, Ziman M. Nestin structure and predicted function in cellular cytoskeletal organisation. Histology and histopathology. 2005;20:665&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">15736068</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu&#xe9;rette D, Khan PA, Savard PE, Vincent M. Molecular evolution of type VI intermediate filament proteins. BMC evolutionary biology. 2007;7:164.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2075511</ArticleId><ArticleId IdType="pubmed">17854500</ArticleId></ArticleIdList></Reference><Reference><Citation>Frade JM, Ovejero-Benito MC. Neuronal cell cycle: the neuron itself and its circumstances. Cell Cycle. 2015;14:712&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4418291</ArticleId><ArticleId IdType="pubmed">25590687</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang C, Zhu L, Gan W, Liang H, Li J, Zhang J. et al. Distributed Features of Vimentin- Containing Neural Precursor Cells in Olfactory Bulb of SOD1G93A Transgenic Mice: a Study about Resource of Endogenous Neural Stem Cells. International journal of biological sciences. 2016;12:1405&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5166483</ArticleId><ArticleId IdType="pubmed">27994506</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner M. Role of GFAP in CNS injuries. Neuroscience letters. 2014;565:7&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4049287</ArticleId><ArticleId IdType="pubmed">24508671</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>